Morphine

Morphine

SCHEMBL6433223

CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.O=C(O)c1ccccc1

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1

The experimentally established mechanism targets of Morphine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 known ✓ P35372 7/20 0.82
▸ OPRD1 P41143 10/20 0.82
▸ OPRK1 P41145 5/20 0.82
▸ MRGPRX2 Q96LB1 2/20 0.82
▸ SLC22A1 O15245 1/20 0.82
▸ ADRA2A P08913 1/20 0.82
▸ ARRB1 P49407 1/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Morphine SCHEMBL6459790 1.00 OPRD1 (0.82) OPRD1OPRM1OPRK1MRGPRX2SLC22A1
Morphine SCHEMBL6120641 0.95 OPRD1 (0.74) OPRD1OPRM1OPRK1MRGPRX2SLC22A1
Morphine SCHEMBL7489416 0.94 OPRD1 (0.81) OPRD1OPRM1OPRK1MRGPRX2SLC22A1
Morphine SCHEMBL3476851 0.93 OPRD1 (0.82) OPRD1OPRM1OPRK1MRGPRX2SLC22A1
Morphine SCHEMBL11045706 0.92 OPRD1 (0.81) OPRD1OPRM1OPRK1MRGPRX2SLC22A1
Morphine SCHEMBL8374708 0.92 OPRD1 (0.90) OPRD1OPRM1OPRK1MRGPRX2SLC22A1
Morphine SCHEMBL15055206 0.92 OPRD1 (0.90) OPRD1OPRM1OPRK1MRGPRX2SLC22A1
Morphine SCHEMBL149700 0.92 OPRD1 (0.90) OPRD1OPRM1OPRK1MRGPRX2SLC22A1
Morphine SCHEMBL3477436 0.91 OPRD1 (0.79) OPRD1OPRM1OPRK1MRGPRX2SLC22A1
Morphine SCHEMBL2443249 0.91 OPRD1 (0.89) OPRD1OPRM1OPRK1MRGPRX2SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1305378-B1 MEDICAL CONTACT ADHESIVE COMPRISING A TWO PHASE ADHESIVE MATRIX OF POLYACRYLATES AND POLYAMINE SALTS LOHMANN THERAPIE SYST LTS (DE) 2005-11-16 — — EP disclosed
EP-1305378-A1 MEDICAL CONTACT ADHESIVE COMPRISING A TWO PHASE ADHESIVE MATRIX OF POLYACRYLATES AND POLYAMINE SALTS LTS Lohmann Therapie-Systeme AG (DE) 2003-05-02 — — EP disclosed
WO-2002008352-A1 MEDICAL CONTACT ADHESIVE COMPRISING A TWO PHASE ADHESIVE MATRIX OF POLYACRYLATES AND POLYAMINE SALTS LTS LOHMANN THERAPIE-SYSTEM AG (DE) 2002-01-31 — — WO disclosed
Send feedback